Literature DB >> 10126527

Statutory definitions of death and the management of terminally ill patients who may become organ donors after death.

D Cole1.   

Abstract

The law stipulates that death is irreversible. Patients treated in accord with the Pittsburgh protocol have death pronounced when their condition might well be reversed by intervention that is intentionally withheld. Nevertheless, the protocol is in accord with the medical "Guidelines for the Determination of Death." However, the Guidelines fail to capture the intent of the law, which turns out to be a good thing, for the law embodies a faulty definition of death. The inclusion of "irreversible" in the legal definition makes that definition excessively demanding and out of step with the ordinary concept of death. On this basis the protocol is absolved of the moral but not the legal charge that it involves vivisection.

Entities:  

Keywords:  Death and Euthanasia; Defining Death; Health Care and Public Health; Legal Approach; President's Commission for the Study of Ethical Problems; Uniform Determination of Death Act; University of Pittsburgh Medical Center

Mesh:

Year:  1993        PMID: 10126527     DOI: 10.1353/ken.0.0025

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  5 in total

1.  Defining death in non-heart beating organ donors.

Authors:  N Zamperetti; R Bellomo; C Ronco
Journal:  J Med Ethics       Date:  2003-06       Impact factor: 2.903

Review 2.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

3.  Organ transplant initiatives: the twilight zone.

Authors:  D P Price
Journal:  J Med Ethics       Date:  1997-06       Impact factor: 2.903

4.  Controversy in the Determination of Death: The Definition and Moment of Death.

Authors:  Frederick J White
Journal:  Linacre Q       Date:  2019-10-13

5.  Pro/con ethics debate: when is dead really dead?

Authors:  Leslie Whetstine; Stephen Streat; Mike Darwin; David Crippen
Journal:  Crit Care       Date:  2005-10-31       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.